How does the brain keep calm? Insight into brain stability and the key role of NMDA receptors

byTel-Aviv UniversityGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.10.014Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor

Updated on: November 28,2024

How does the brain keep calm? Insight into brain stability and the key role of NMDA receptors

byTel-Aviv UniversityGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.10.014Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor

Updated on:November 28,2024

Breaking stereotype: Brain models are not one-size-fits-all

by Yale UniversityCredit: Pixabay/CC0 Public DomainMachine learning has helped scientists understand how the brain gives rise to complex human characteristics, uncovering patterns of brain activi

Updated on: February 18,2024

Breaking stereotype: Brain models are not one-size-fits-all

by Yale UniversityCredit: Pixabay/CC0 Public DomainMachine learning has helped scientists understand how the brain gives rise to complex human characteristics, uncovering patterns of brain activi

Updated on:February 18,2024

Anticoagulants fail to prevent unexplained strokes, clinical trial finds

by Columbia University Irving Medical CenterVisual Abstract.Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. Credit:JAMA, (2024). doi:10.10

Updated on: May 21,2024

Anticoagulants fail to prevent unexplained strokes, clinical trial finds

by Columbia University Irving Medical CenterVisual Abstract.Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. Credit:JAMA, (2024). doi:10.10

Updated on:May 21,2024

Towards better management of disinhibition in frontotemporal dementia

by Marie Simon,Paris Brain InstituteReconstruction of a waiting room for the ECOCAPTURE study. Credit: FrontLab, Paris Brain InstituteDisinhibition is one of the main symptoms of the behavioral

Updated on: June 05,2024

Towards better management of disinhibition in frontotemporal dementia

by Marie Simon,Paris Brain InstituteReconstruction of a waiting room for the ECOCAPTURE study. Credit: FrontLab, Paris Brain InstituteDisinhibition is one of the main symptoms of the behavioral

Updated on:June 05,2024

Researchers one step closer to preventing preeclampsia

by American Physiological SocietyCredit:Physiological Genomics(2024). DOI: 10.1152/physiolgenomics.00058.2023Researchers have identified several differences in DNA methylation in peop

Updated on: March 19,2024

Researchers one step closer to preventing preeclampsia

by American Physiological SocietyCredit:Physiological Genomics(2024). DOI: 10.1152/physiolgenomics.00058.2023Researchers have identified several differences in DNA methylation in peop

Updated on:March 19,2024

Eli Lilly changes outcome goals in Alzheimer's drug study

by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E

Updated on: February 28,2024

Eli Lilly changes outcome goals in Alzheimer's drug study

by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E

Updated on:February 28,2024

New insights into the formation of toxic protein clumps in Alzheimer's disease

byForschungszentrum JuelichSmall Aβ oligomers (left: cryo-electron microscopy) are clumps consisting of just a few Aβ molecules. They cluster together to form short, worm-like structures known a

Updated on: April 18,2024

New insights into the formation of toxic protein clumps in Alzheimer's disease

byForschungszentrum JuelichSmall Aβ oligomers (left: cryo-electron microscopy) are clumps consisting of just a few Aβ molecules. They cluster together to form short, worm-like structures known a

Updated on:April 18,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on: April 25,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on:April 25,2024

Study confirms cognitive deficits in people with the rare disease MOGAD

by Stefan Zorn, Medizinische Hochschule HannoverMean z-scores of neuropsychological tests at baseline (patients <60 years). PASAT, Paced Auditory Serial Addition Task; SDMT, Symbol Digit Modalities

Updated on: November 12,2024

Study confirms cognitive deficits in people with the rare disease MOGAD

by Stefan Zorn, Medizinische Hochschule HannoverMean z-scores of neuropsychological tests at baseline (patients <60 years). PASAT, Paced Auditory Serial Addition Task; SDMT, Symbol Digit Modalities

Updated on:November 12,2024

Clinical trial finds herbal medicine Sailuotong effective for brain health in older people

by Western Sydney UniversityCredit: Pixabay/CC0 Public DomainWestern Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope

Updated on: March 02,2024

Clinical trial finds herbal medicine Sailuotong effective for brain health in older people

by Western Sydney UniversityCredit: Pixabay/CC0 Public DomainWestern Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope

Updated on:March 02,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on: March 07,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on:March 07,2024

Novel algorithm improves intracranial EEG accuracy to enhance future patient care

byUniversity of Minnesota Medical SchoolThe ABCD Algorithm. (A) Example raw log-power spectra from 152 channels during a single recording session. (B) Example, mean log-power spectrum and second

Updated on: September 06,2024

Novel algorithm improves intracranial EEG accuracy to enhance future patient care

byUniversity of Minnesota Medical SchoolThe ABCD Algorithm. (A) Example raw log-power spectra from 152 channels during a single recording session. (B) Example, mean log-power spectrum and second

Updated on:September 06,2024